Mise à niveau vers Pro

  • The Global Catheter Industry is on track for significant expansion, with a projected valuation exceeding US$23.28 billion by 2033. This growth trajectory reflects a compelling Compound Annual Growth Rate (CAGR) of 6.3% anticipated from 2023 to 2033. The market already boasts a substantial presence, reaching an estimated value of US$12.59 billion in 2023. This strong foundation positions the market for a promising future.

    Cardiac catheters are projected to witness high demand owing to their growing usage in heart treatment procedures like angiograms and angioplasty. They are highly renowned for reducing infections and complications, making them equally preferred among patients.

    The global catheter market is poised for substantial growth, driven by several factors. These include the increasing prevalence of cardiovascular, neurologic, and urological disorders. A rising preference for minimally invasive procedures and the growing demand for antimicrobial catheters are also crucial market drivers. Chronic disorders have become a leading cause of mortality and morbidity worldwide, underscoring the market’s significance.

    The worldwide demand for catheters is expected to increase due to the rising popularity of minimally invasive surgeries, as people prefer less invasive treatments. Leading market participants are also introducing new items to satisfy this need.

    A novel coronary drug-coated balloon (DCB) developed for percutaneous coronary intervention (PCI) treatments in patients with coronary artery disease (CAD) is the Prevail DCB catheter. Medtronic plc debuted this product in Europe in July 2021. With the increased popularity of minimally invasive treatments, the introduction of similar products is anticipated to accelerate the use of catheters to treat cardiovascular disease.

    Request a Sample Copy of the Report:
    https://www.futuremarketinsights.com/reports/sample/rep-gb-17999

    Global Catheter Industry Key Takeaways:

    The global catheter market stood at around US$ 11930.3 million in 2022.
    The hospital segment by end-use is set to showcase a steady CAGR of 5.7% through 2033.
    The acute kidney injury segment, by indication, is estimated to register a significant CAGR of 8.1% in the forecast period.
    The intravenous catheters segment by product accounted for a dominant share of 64.4% in 2022 in the global catheter industry.
    The United Kingdom is estimated to register an average CAGR of 6.1% during the forecast period in the catheter industry.
    “It is anticipated that catheters would be employed for diagnostic procedures, including hemodialysis and electrophysiological tests. Globally, it is anticipated that there will be an increasing demand for effective medical services due to the rising prevalence of diseases, such as cancer, acute illness, and trauma. To provide appropriate care, it is expected that medical practitioners will use peripherally inserted central catheters (PICC) more frequently in hospitals, operating rooms, and emergency departments,” opines Sabyasachi Ghosh, Associate Vice President at Future Market Insights (FMI) analyst.

    Global Catheter Industry Competitive Landscape:

    The improvement of product features is a top priority for leading players in the catheter industry as a way to strengthen their positions. They also want to increase their presence in emerging areas.

    Entering into strategic collaborations and agreements with other businesses is a key tactic used by top manufacturers to keep their dominance in the catheter market. It is predicted that these tactics will aid them in extending the reach of their firm.

    For instance,

    Coloplast introduced the cutting-edge intermittent catheter Luja in February 2023 to address significant UTI risk factors. These place a heavy burden on both people who use intermittent catheters and the healthcare system as a whole. The first and only male catheter with more than 80 micro-holes, Luja, was created to help address severe UTI risk factors related to intermittent catheterization.
    Cardinal Health and Kinaxis entered into a collaboration agreement in February 2022 to improve the visibility of medical products and the efficiency of the supply chain.
    Buy The Full Report of Global Catheter Industry Analysis
    https://www.futuremarketinsights.com/checkout/17999

    Global Catheter Industry Segmentation:

    By Product:

    Urinary Catheters
    Foley Catheters
    Intermittent Catheters
    External Catheters
    Compact Catheters
    Intravenous Catheters
    Peripheral Catheters
    Short Peripheral IV Catheter
    Integrated/Closed PIVC
    Central Venous Catheters
    Peripherally Inserted Central Catheters (PICC)
    Implanted Port
    Tunneled Central Venous Catheters
    Non-tunneled Central Venous Catheters
    Hemodialysis Catheters
    Cuffed Tunneled Catheter
    Non-cuffed Tunneled Catheters
    Non-tunneled Catheters
    By Indication:

    Urinary Incontinence
    Urethral Stricture
    Chronic Obstruction
    Neurogenic Bladder
    Enlarged Prostate Gland/BPH
    Prostate Cancer
    Acute Kidney Injury
    Others
    By End-user:

    Hospitals
    Dialysis Centers
    Long-term Care Facilities
    Ambulatory Surgical Centers
    Home Care
    By Region:

    North America
    Latin America
    Europe
    South Asia
    East Asia
    Oceania
    Middle East & Africa
    The Global Catheter Industry is on track for significant expansion, with a projected valuation exceeding US$23.28 billion by 2033. This growth trajectory reflects a compelling Compound Annual Growth Rate (CAGR) of 6.3% anticipated from 2023 to 2033. The market already boasts a substantial presence, reaching an estimated value of US$12.59 billion in 2023. This strong foundation positions the market for a promising future. Cardiac catheters are projected to witness high demand owing to their growing usage in heart treatment procedures like angiograms and angioplasty. They are highly renowned for reducing infections and complications, making them equally preferred among patients. The global catheter market is poised for substantial growth, driven by several factors. These include the increasing prevalence of cardiovascular, neurologic, and urological disorders. A rising preference for minimally invasive procedures and the growing demand for antimicrobial catheters are also crucial market drivers. Chronic disorders have become a leading cause of mortality and morbidity worldwide, underscoring the market’s significance. The worldwide demand for catheters is expected to increase due to the rising popularity of minimally invasive surgeries, as people prefer less invasive treatments. Leading market participants are also introducing new items to satisfy this need. A novel coronary drug-coated balloon (DCB) developed for percutaneous coronary intervention (PCI) treatments in patients with coronary artery disease (CAD) is the Prevail DCB catheter. Medtronic plc debuted this product in Europe in July 2021. With the increased popularity of minimally invasive treatments, the introduction of similar products is anticipated to accelerate the use of catheters to treat cardiovascular disease. Request a Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-17999 Global Catheter Industry Key Takeaways: The global catheter market stood at around US$ 11930.3 million in 2022. The hospital segment by end-use is set to showcase a steady CAGR of 5.7% through 2033. The acute kidney injury segment, by indication, is estimated to register a significant CAGR of 8.1% in the forecast period. The intravenous catheters segment by product accounted for a dominant share of 64.4% in 2022 in the global catheter industry. The United Kingdom is estimated to register an average CAGR of 6.1% during the forecast period in the catheter industry. “It is anticipated that catheters would be employed for diagnostic procedures, including hemodialysis and electrophysiological tests. Globally, it is anticipated that there will be an increasing demand for effective medical services due to the rising prevalence of diseases, such as cancer, acute illness, and trauma. To provide appropriate care, it is expected that medical practitioners will use peripherally inserted central catheters (PICC) more frequently in hospitals, operating rooms, and emergency departments,” opines Sabyasachi Ghosh, Associate Vice President at Future Market Insights (FMI) analyst. Global Catheter Industry Competitive Landscape: The improvement of product features is a top priority for leading players in the catheter industry as a way to strengthen their positions. They also want to increase their presence in emerging areas. Entering into strategic collaborations and agreements with other businesses is a key tactic used by top manufacturers to keep their dominance in the catheter market. It is predicted that these tactics will aid them in extending the reach of their firm. For instance, Coloplast introduced the cutting-edge intermittent catheter Luja in February 2023 to address significant UTI risk factors. These place a heavy burden on both people who use intermittent catheters and the healthcare system as a whole. The first and only male catheter with more than 80 micro-holes, Luja, was created to help address severe UTI risk factors related to intermittent catheterization. Cardinal Health and Kinaxis entered into a collaboration agreement in February 2022 to improve the visibility of medical products and the efficiency of the supply chain. Buy The Full Report of Global Catheter Industry Analysis https://www.futuremarketinsights.com/checkout/17999 Global Catheter Industry Segmentation: By Product: Urinary Catheters Foley Catheters Intermittent Catheters External Catheters Compact Catheters Intravenous Catheters Peripheral Catheters Short Peripheral IV Catheter Integrated/Closed PIVC Central Venous Catheters Peripherally Inserted Central Catheters (PICC) Implanted Port Tunneled Central Venous Catheters Non-tunneled Central Venous Catheters Hemodialysis Catheters Cuffed Tunneled Catheter Non-cuffed Tunneled Catheters Non-tunneled Catheters By Indication: Urinary Incontinence Urethral Stricture Chronic Obstruction Neurogenic Bladder Enlarged Prostate Gland/BPH Prostate Cancer Acute Kidney Injury Others By End-user: Hospitals Dialysis Centers Long-term Care Facilities Ambulatory Surgical Centers Home Care By Region: North America Latin America Europe South Asia East Asia Oceania Middle East & Africa
    WWW.FUTUREMARKETINSIGHTS.COM
    Catheter Market - Sample | Future Market Insights
    Get you queries resolved from our expert analysts who will assist with all your research needs and customize the report
    ·162 Vue
  • https://www.digiesales.com/dr-shashanka-dhanuka-a-leading-urologist-bringing-hope-to-kolkata/

    https://medium.com/@drshashankadhanuka/dr-shashanka-dhanuka-the-premier-consultant-urologist-in-kolkata-76df121537b

    https://www.zupyak.com/p/3894711/t/advancing-urological-health-a-deep-dive-into-dr-shashanka-dhanukas-specialized-treatments

    https://medium.com/@drshashankadhanuka/prostate-cancer-symptoms-risk-factors-prevention-treatment-dr-shashanka-dhanuka-0cb55680da30
    https://www.digiesales.com/dr-shashanka-dhanuka-a-leading-urologist-bringing-hope-to-kolkata/ https://medium.com/@drshashankadhanuka/dr-shashanka-dhanuka-the-premier-consultant-urologist-in-kolkata-76df121537b https://www.zupyak.com/p/3894711/t/advancing-urological-health-a-deep-dive-into-dr-shashanka-dhanukas-specialized-treatments https://medium.com/@drshashankadhanuka/prostate-cancer-symptoms-risk-factors-prevention-treatment-dr-shashanka-dhanuka-0cb55680da30
    Dr. Shashanka Dhanuka A Leading Urologist Bringing Hope to Kolkata
    ·137 Vue
/